Is Alzheimer’s Research Focusing on the Wrong Target? David Brzostowicki July 09, 2026

https://www.medscape.com/viewarticle/alzheimers-research-focusing-wrong-target-2026a1000nal In April, a meta-analysis published in the Cochrane Database of Systematic Reviews pooled 17 randomized controlled trials involving more than 20,000 patients with mild cognitive impairment or mild dementia due to Alzheimer’s disease (AD) and concluded that antiamyloid monoclonal antibodies clear amyloid-beta from the brain but produce little-to-no effect on cognition and dementia severity.